|
|
|
|
|
by DanBC
3967 days ago
|
|
> Now take a look at the recent articles on the UK's much hyped NHS and how they are laggards in cancer survival because they do not take advantage of pharma innovations. That's definitely not the reason why the NHS has poor cancer outcomes. Those very expensive new cancer meds add a month or so of low quality life (and are used within the NHS). The problem is at the diagnosis end. |
|
Look at the five year survival rates for innovative treatments. Granted not all of them and not every time, but to generalize to "months" is a gross mis-characterization not borne out by a thorough review of the literature.